Tyra Biosciences (TYRA) Change in Acquisitions & Divestments (2024 - 2026)

Tyra Biosciences has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $42.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 8.07% year-over-year to $42.0 million; the trailing twelve-month figure through Mar 2026 stood at $177.0 million (up 1.26% YoY), and the FY2025 full-year result was $173.9 million, up 4.81% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $42.0 million, down from $43.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $58.0 million in Q3 2024, with the low at $30.0 million in Q1 2024.
• Historically, Change in Acquisitions & Divestments has averaged $42.4 million across 3 years, with a median of $42.0 million in 2026.
• The largest YoY upside for Change in Acquisitions & Divestments was 29.7% in 2025 against a maximum downside of 13.09% in 2025.
• Tyra Biosciences' Change in Acquisitions & Divestments stood at $45.0 million in 2024, then declined by 3.24% to $43.5 million in 2025, then decreased by 3.42% to $42.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $42.0 million (Q1 2026), $43.5 million (Q4 2025), and $50.4 million (Q3 2025), per Business Quant data.